U.S. plans shift of Merck’s COVID-19 treatment to commercial market

U.S. plans shift of Merck’s COVID-19 treatment to commercial market

Upworthy

Published

The U.S. government will stop distributing free doses of Merck & Co’s COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead. The Administration for Strategic Preparedness and Response (ASPR), a division of the U.S.…

#merckcoscovid19 #response #merck #pfizer #aspr

Full Article